The effects of urokinase-type plasminogen activator (uPA) on cell proliferation and phenotypic transformation of rat mesangial cells induced by high glucose

Diabetes Research and Clinical Practice

Volumn 103, Issue 3, 2014, Pages 489-495

  Cheng, Hui ^a   Chen, Cheng ^a   Wang, Siyuan ^a   Ding, Guohua ^a   Shi, Ming ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Mesangial cells (MC) proliferation; Signal transduction; Urokinase type plasminogen activator (uPA)

Indexed keywords

MESANGIAL CELLS (MC) PROLIFERATION; SIGNAL TRANSDUCTION; UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA);

ACTINS; ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; DIABETES MELLITUS, EXPERIMENTAL; FLOW CYTOMETRY; GLUCOSE; MALE; MESANGIAL CELLS; MICROSCOPY, CONFOCAL; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SWEETENING AGENTS; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84898853227     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.11.016     Document Type: Article

References (14)

1. Zhang G., Eddy A.A. Urokinase and its receptors in chronic kidney disease. Front Biosci 2008, 13:5462-5478.
2. Kenichi M., Masanobu M., Takehiko K., Shoko T., Akira F., Katsushige A., et al. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor. J Lab Clin Med 2004, 144:69-77.
3. Baccora M.H., Cortes P., Hassett C., Taube D.W., Yee J., et al. Effects of long-term elevated glucose on collagen formation by mesangial cells. Kidney Int 2007, 72(10):1216-1225.
4. McLennan S.V., Yue D.K., Turtle J.R. Effect of glucose on matrix metalloproteinase activity in mesangial cells. Nephron 1998, 79:293-298.
5. Bohlender J.M., Franke S., Stein G., Wolf G. Advanced glycation end products and the kidney. Am J Physiol Renal Physiol 2005, 289(October (4)):F645-F659.
6. Eddy A.A., Fogo A.B. Plasminogen Activator Inhibitor-1 in Chronic Kidney Disease: Evidence and Mechanisms of Action. J Am Soc Nephrol 2006, 17:2999-3012.
7. Chunsheng X., Xiangmei C., Xuefeng S., Shi S., Feng Z., Wang J., et al. Effects of alterations of glomerular fibrin deposition on renal inflammation in rats at different age stages. J Gerontol A Biol Sci Med Sci 2005, 60:1099-1110.
8. Shushakova N.N., Tkachuk M., Dangers S., Tkachuk S., Park J.K., Hashimoto K., et al. Urokinase-induced activation of the gp130/Tyk2/Stat3 pathway mediates a pro-inflammatory effect in human mesangial cells via expression of the anaphylatoxin C5a receptor. J Cell Sci 2005, 118:2743-2753.
9. Shetty S., Gadiparthi N.R., Douglas B.C., Khalil B. Urokinase induces activation of STAT3 in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 2006, 291:772-780.
10. Wei Y., Czekay R.P., Robillard L., Kugler M.C., Zhang F., Kim K.K., et al. Regulation of alpha 5 beta 1 integrin conformation and function by urokinase receptor binding. J Cell Biol 2005, 168:501-511.
11. Dass K., Ahmad A., Azmi A.S., Sarkar S.H., Saekar F.H. Evolving role of uPA/uPAR system in human cancers. Cancer Treat Rev 2008, 34:122-136.
12. Collins S.J., Alexander S.L., Lopez-Guisa J.M., Cai X., Maruvada R., Chua S.C., et al. Plasminogen activator inhibitor 1 deficiency has renal benefits but some adverse systemic consequences in diabetic mice. Nephron Exp. Nephrol 2006, 104:e23-e34.
13. Rebecca Chin Y., Alex T. Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer. Cell Signal 2009, 21(April (4)):470-476.
14. Tian Lan, Weihua Liu, Xi Xie, Kaipeng Huang, Jing Peng, Juan Huang, et al. Berberine suppresses high glucose-induced TGF-b1 and fibronectin synthesis in mesangial cells through inhibition of sphingosine kinase 1/AP-1 pathway. Eur J Pharmacol 2012, 697:165-172.